SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Aridis Pharmaceuticals Q3 EPS $(0.87) Up From $(1.97) YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.87) per share. This is a 55.84 percent increase over losses of $(1.97) per share from the same period last year.

Benzinga · -

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.87) per share. This is a 55.84 percent increase over losses of $(1.97) per share from the same period last year.